BWL
MDGL icon

Bogart Wealth LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bogart Wealth LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Buy
2
+1
+100% +$512 ﹤0.01% 1604
2026
Q1 		$523 Hold
1
– – ﹤0.01% 1574
2025
Q4 		$582 Hold
1
– – ﹤0.01% 1416
2025
Q3 		$459 Buy
+1
New +$373 ﹤0.01% 1450

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bogart Wealth LLC's MDGL Position: Q2 2026 in Review

Bogart Wealth LLC increased its Madrigal Pharmaceuticals (MDGL) stake by 100% in Q2 2026, buying an estimated $512 and bringing the position to 2 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Bogart Wealth LLC first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Bogart Wealth LLC held 2 shares of Madrigal Pharmaceuticals worth $1.07K as of Q2 2026.
  • Bogart Wealth LLC bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1604 holding.
  • Bogart Wealth LLC first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.